Association of Cerebral Metabolic Activity Changes with Vagus Nerve Stimulation Antidepressant Response in Treatment-Resistant Depression |
| |
Authors: | Charles R Conway John T Chibnall Marie Anne Gebara Joseph L Price Abraham Z Snyder Mark A Mintun AD Craig Martha E Cornell Dana C Perantie Luis A Giuffra Richard D Bucholz Yvette I Sheline |
| |
Institution: | 1. Department of Psychiatry, Washington University, St. Louis, MO, USA;2. Department of Neurology and Psychiatry, Saint Louis University, St. Louis, MO, USA;3. Department of Anatomy and Neurobiology, Washington University, St. Louis, MO, USA;4. Department of Neurology, Washington University, St. Louis, MO, USA;5. Department of Radiology, Washington University, St. Louis, MO, USA;6. Avid Radiopharmaceuticals, Philadelphia, PA, USA;7. Atkinson Research Laboratory, Barrow Neurological Institute, Phoenix, AZ, USA;8. Department of Neurosurgery, Saint Louis University, St. Louis, MO, USA |
| |
Abstract: | BackgroundVagus nerve stimulation (VNS) has antidepressant effects in treatment resistant major depression (TRMD); these effects are poorly understood. This trial examines associations of subacute (3 months) and chronic (12 months) VNS with cerebral metabolism in TRMD.Objective17Fluorodeoxyglucose positron emission tomography was used to examine associations between 12-month antidepressant VNS response and cerebral metabolic rate for glucose (CMRGlu) changes at 3 and 12 months.MethodsThirteen TRMD patients received 12 months of VNS. Depression assessments (Hamilton Depression Rating Scale HDRS]) and PET scans were obtained at baseline (pre-VNS) and 3/12 months. CMRGlu was assessed in eight a priori selected brain regions (bilateral anterior insular AIC], orbitofrontal OFC], dorsolateral prefrontal DLPFC], and anterior cingulate cortices ACC]). Regional CMRGlu changes over time were studied in VNS responders (decreased 12 month HDRS by ≥50%) and nonresponders.ResultsA significant trend (decreased 3 month CMRGlu) in the right DLPFC was observed over time in VNS responders (n = 9; P = 0.006). An exploratory whole brain analysis (Puncorrected = 0.005) demonstrated decreased 3 month right rostral cingulate and DLPFC CMRGlu, and increased 12 month left ventral tegmental CMRGlu in responders.Conclusions/LimitationsVNS response may involve gradual (months in duration) brain adaptations. Early on, this process may involve decreased right-sided DLPFC/cingulate cortical activity; longer term effects (12 months) may lead to brainstem dopaminergic activation. Study limitations included: a) a small VNS nonresponders sample (N = 4), which limited conclusions about nonresponder CMRGlu changes; b) no control group; and, c) patients maintained their psychotropic medications. |
| |
Keywords: | |
本文献已被 ScienceDirect 等数据库收录! |
|